mr 2034 has been researched along with d-ala(2),mephe(4),met(0)-ol-enkephalin in 1 studies
Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (d-ala(2),mephe(4),met(0)-ol-enkephalin) | Trials (d-ala(2),mephe(4),met(0)-ol-enkephalin) | Recent Studies (post-2010) (d-ala(2),mephe(4),met(0)-ol-enkephalin) |
---|---|---|---|---|---|
48 | 0 | 0 | 293 | 24 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Männistö, PT; Rauhala, P; Tuominen, RK | 1 |
1 other study(ies) available for mr 2034 and d-ala(2),mephe(4),met(0)-ol-enkephalin
Article | Year |
---|---|
Opiate receptor subtypes in the regulation of thyrotropin and prolactin secretion in the rat.
Topics: Animals; Benzomorphans; Cerebral Ventricles; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Injections, Intraventricular; Kinetics; Male; Morphinans; Prolactin; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reference Values; Thyrotropin | 1988 |